Alpha-amylase inhibition kinetics by caulerpenyne

Mediterranean Marine Science

Volumn 11, Issue 1, 2010, Pages 93-103

  Cengiz, S ^a   Cavas, L ^a   Yurdakoc, K ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Alpha amylase; Caulerpenyne; Inhibition kinetic

Indexed keywords

EID: 79955964193     PISSN: 1108393X     EISSN: 17916763     Source Type: Journal    
DOI: 10.12681/mms.93     Document Type: Article

References (37)

1. AGUILAR-SANTAMARÍA, L., RAMÍREZ, G., NICASIO, P., ALEGRÍA-REYES, C. & HERRERA-ARELLANO, A., 2009. Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth. Journal of Ethnopharmacology, 124 (2): 284-288.
2. ALI, H., HOUGHTON, P.J. & SOUMYANATH, A., 2006. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. Journal of Ethnopharmacology, 107 (3): 449-455.
3. AMADE, P. & LEMEE, R, 1998. Chemical defence of the mediterranean alga Caulerpa taxifolia: variations in caulerpenyne production. Aquatic Toxicology, 43 (4): 287-300.
4. AMICO, V., ORIENTE, G., PIATTELLI, M. & TRINGALI, C., 1978. Caulerpenyne, an unusual sequiterpenoid from the green alga Caulerpa prolifera. Tetrahedron Letters, 38 (20): 3593-3596.
5. BARBIER, P., GUISE, S., HUITOREL, P., AMADE, P., PESANDO, D., BRIAND, C. & PEYROT, V., 2001. Caulerpenyne from Caulerpa taxifolia has an antiproliferative activity on tumor cell line SK-N-SH and modifies the microtubule network. Life Sciences, 70 (4): 415-429.
6. BERNFELD, P., 1951. Enzymes of Starch Degradation and Synthesis. p. 379-428. In: Advances in Enzymology, Nord. F.F. (Ed), Interscience Publishers, New York.
7. BHANDARI, M.R., JONG-ANURAKKUN, N., HONG, G. & KAWABATA, J., 2008. α-Glucosidase and α-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw.). Food Chemistry, 106 (1): 247-252.
8. BISCHOFF, H., 1994. Pharmacology of alpha-glucosidase inhibition. European Journal of Clinical Investigation, 24 (1): 3-10.
9. BITOU, N., NINOMIYA, M., TSUJITA, T. & OKUDA, H., 1999. Screening of Lipase Inhibitors from Marine Algae. Lipids, 34 (5): 441-445.
10. BOX, A., SUREDA, A., TERRADOS, J., PONS, A. & DEUDERO, S., 2008. Antioxidant response and caulerpenyne production of the alien Caulerpa taxifolia (Vahl) epiphytized by the invasive algae Lophocladia lallemandii (Montagne). Journal of Experimental Marine Biology & Ecology, 364 (1): 24-28.
11. CAVAS, L., BASKIN, Y., YURDAKOC, K. & OLGUN, N., 2006. Antiproliferative and newly attributed apoptotic activities from an invasive marine alga: Caulerpa racemosa var. cylindracea. Journal of Experimental Marine Biology & Ecology, 339 (1): 111-119.
12. CHAKRABARTI, R. & RAJAGOPALAN, R., 2002. Diabetes and insulin resistance associated disorders: Disease and therapy. Current Science, 83 (12): 1533-1538.
13. CHETHAN, S., SREERAMA, Y.N. & MALLESHI, N.G., 2008. Mode of inhibition of finger millet malt amylases by the millet phenolics. Food Chemistry, 111 (1): 187-191.
14. DIXON, M., 1953. The determination of enzyme inhibitor constants. Biochemical Journal, 55 (1): 170-171.
15. FARIAS, L.R., COSTA, F.T., SOUZA, L.A., PELEGRİNİ, P.B., GROSSİ-de-SÁ, M.F., NETO, S.M., BLOCH Jr., C., LAUMANN, R.A., NORONHA, E.F. & FRANCO, O.L., 2007. Isolation of a novel Carica papaya (-amylase inhibitor with deleterious activity toward Callosobruchus maculatus. Pesticide Biochemistry & Physiology, 87 (3): 255-260.
16. FISCHEL, J.L., LEMÉE, R., FORMENTO, P., CALDANI, C., MOLL, J.L., PESANDO, D., MEINESZ, A., GRELIER, P., PIETRA, P., GUERRIERO, A. & MILANO, G., 1995. Cell growth inhibitory effects of Caulerpenyne, a sesquiterpenoid from the marine algae Caulerpa taxifolia. Anticancer Research, 15 (5B): 2155-2160.
17. FRED-JAIYESIMI, A., KIO, A. & RICHARD, W., 2009. α-Amylase inhibitory effect of 3β-olean-12-en-3-yl (9Z)-hexadec-9-enoate isolated from Spondias mombin leaf. Food Chemistry, 116 (1): 285-288.
18. GALGANI, I., PESANDO, D., PORTHENIBELLE, J., FOSSAT, B. & GIRARD, J.P., 1996. Effect of caulerpenyne, a toxin extracted from Caulerpa taxifolia on mechanisms regulating intracellular pH in sea urchin eggs and sea bream hepatocytes. Journal of Biochemical Toxicology, 11 (5): 243-250.
19. GROVER, J.K., YADAV, S. & VATS, V., 2002. Medicinal plants of India with antidiabetic potential. Journal of Ethnopharmacology, 81 (1): 81-100.
20. HEIDARI, R., ZAREAE, S. & HEIDARIZADEH, M., 2005. Extraction, Purification, and Inhibitory Effect of Alpha-Amylase Inhibitor from Wheat (Triticum aestivum var. Zarrin). Pakistan Journal of Nutrition, 4 (2): 101-105.
21. JUNG, V., THIBAUT, T., MEINESZ, A. & POHNERT, G., 2002. Comparison of the Wound-Activated Transformation of Caulerpenyne by Invasive and Noninvasive Caulerpa Species of the Mediterranean. Journal of Chemical Ecology, 28 (10): 2091-2105.
22. KIMMEL, B. & INZUCCHI, S., 2005. Oral agents for type 2 diabetes: An update. Clinical Diabetes, 23: 64-76.
23. LEME'E, R., PESANDO, D., DURANDCLEMENT, M., DUBREUIL, A., MEINESZ, A., GUERRIERO, A. & PIETRA, F., 1993. Preliminary survey of toxicity of the green alga Caulerpa taxifolia introduced into the Mediterranean. Journal of Applied Phycology, 5 (5): 485-493.
24. LOIZZO, M.R., SAAB, A.M., TUNDIS, R., MENICHINI, F., BONESI, M., PICCOLO, V., STATTI, G.A., de CINDIO, B., HOUGHTON, P.J. & MENICHINI, F., 2008. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. Journal of Ethnopharmacology, 119 (1): 109-116.
25. MARLES, R. & FARNSWORTH, N., 1994. Plants as sources of antidiabetic agents. p. 149-187. In: Economic and Medicinal Plant Research, Wagner, H. & Farnsworth, N.R. (Eds), Academic Press Ltd., UK.
26. MATSUI, T., TANAKA, T., TAMURA, S., TOSHIMA, A., MIYATA, Y. & TANAKA, K., 2007. Alpha-glucosidase inhibitory profile of catechins and theaflavins. Journal of Agricultural & Food Chemistry, 55 (1): 99-105.
27. MAYER, A.M.S., PAUL, V.J., FENICAL, W., NORRIS, J.N., CARVALHO, M.S. & JACOBS, R.S., 1993. Phospholipase A2 inhibitors from marine algae. Hydrobiologia, 260-261 (1): 521-529.
28. NICOLETTI, E., DELLA PIETA, F., CALDERONE, V., BANDECCHI, P., PISTELLO, M., MORELLI, I. & CINELLI, F., 1999. Antiviral properties of a crude extract from a green alga Caulerpa taxifolia (Vahl) C Agardh. Phytotherapy Research, 13 (3): 245-247.
29. NINOMIYA, M., ONISHI, J. & KUSUMI, T., 1998. 12-Lipoxygenase inhibitory activity of Japanase seaweeds and isolation of caulerpenyne derivative from green alga Caulerpa taxifolia as an inhibitor. Fisheries Science, 64: 346-347.
30. OCTIVIO, L. & RIGDEN, D., 2000. Activity of wheat α-amylase inhibitors towards bruchid (-amylase and structural explanation of observed specificities. European Journal of Biochemistry, 267 (8): 2166-2173.
31. REBAH, F.B., SMAOUI, S., FRIKHA, F., GARGOURI Y. & MILED, N., 2008. Inhibitory Effects of Tunisian Marine Algal Extracts on Digestive Lipases. Applied Biochemistry & Biotechnology, 151 (1): 71-79.
32. SEGURA, J. & RUILOPE, L.M., 2006. Antihypertensive therapy in patients with metabolic syndrome. Current Opinion Nephrology Hypertension, 15 (5): 493-497.
33. SHIM, Y.J., DOO, H.K., AHN, S.Y., KIM, Y.S., SEONG J.K., PARK, I.S. & MIN, B.H., 2003. Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. Journal of Ethnopharmacology, 85 (2-3): 283-287.
34. SHOBANA, S., SREERAMA, Y.N. & MALLESHI, N.G., 2009. Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of α-glucosidase and pancreatic amylase. Food Chemistry, 115 (4): 1268-1273.
35. SUREDA, A., BOX, A., DEUDERO, S. & PONS, A., 2009. Reciprocal effects of caulerpenyne and intense herbivorism on the antioxidant response of Bittium reticulatum and Caulerpa taxifolia. Ecotoxicology & Environmental Safety, 72 (3): 795-801.
36. TEIXEIRA, V.L., ROCHA, F.D., HOUGHTON, P.J., KAPLAN, M.A.C. & PEREIRA, R.C., 2007. α-Amylase inhibitors from Brazilian seaweeds and their hypoglycemic potential. Fitoterapia, 78 (1): 35-36.
37. WHO, 2002. Traditional medicine strategy 2002-2005. WHO Publications, Geneva, 61 pp.